NCT00386555View on ClinicalTrials.gov

A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2007

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

docetaxel

DRUG

CP-868,596 + docetaxel

DRUG

AG-013736 + docetaxel

DRUG

CP-868,596 + AG-013736 + docetaxel

Sponsors
All Listed Sponsors
lead

Arog Pharmaceuticals, Inc.

INDUSTRY